The METEX study: Methotrexate versus expectant management in women with ectopic pregnancy: A randomised controlled trial
<p>Abstract</p> <p>Background</p> <p>Patients with ectopic pregnancy (EP) and low serum hCG concentrations and women with a pregnancy of unknown location (PUL) and plateauing serum hCG levels are commonly treated with systemic methotrexate (MTX). However, there is no ev...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-06-01
|
Series: | BMC Women's Health |
Online Access: | http://www.biomedcentral.com/1472-6874/8/10 |